Literature DB >> 23338962

Microbial transformation of ginsenoside Rb1 to compound K by Lactobacillus paralimentarius.

Lin-Hu Quan1, Yeon-Ju Kim, Guan Hao Li, Kwang-Tea Choi, Deok-Chun Yang.   

Abstract

In this study, the major ginsenoside Rb1 was transformed into the more pharmacologically active minor compound K by food grade Lactobacillus paralimentarius LH4, which was isolated from kimchi, a traditional Korean fermented food. The enzymatic reaction was analyzed by TLC, HPLC, and NMR. Using the cell-free enzyme of Lactobacillus paralimentarius LH4 at optimal conditions for 30 °C at pH 6.0, 1.0 mg ml(-1) ginsenoside Rb1 was transformed into 0.52 mg ml(-1) compound K within 72 h, with a corresponding molar conversion yield of 88 %. The cell-free enzyme hydrolyzed the two glucose moieties attached to the C-3 position and the outer glucose moiety attached to the C-20 position of the ginsenoside Rb1. The cell-free enzyme hydrolyzed the ginsenoside Rb1 along the following pathway: ginsenoside Rb1 → gypenoside XVII and ginsenoside Rd → ginsenoside F2 → compound K. Our results indicate that Lactobacillus paralimentarius LH4 has the potential to be applied for the preparation of compound K in the food industry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23338962     DOI: 10.1007/s11274-013-1260-1

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  23 in total

1.  Microbial transformation of ginsenoside Rg3 to ginsenoside Rh2 by Esteya vermicola CNU 120806.

Authors:  Jingang Hou; Jianjie Xue; Chunyan Wang; Lei Liu; Dongliang Zhang; Zhen Wang; Wei Li; Yinan Zheng; Changkeun Sung
Journal:  World J Microbiol Biotechnol       Date:  2011-11-16       Impact factor: 3.312

2.  Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia.

Authors:  Le-Qin Cheng; Myung Kyum Kim; Jun-Won Lee; Youn-Jin Lee; Deok-Chun Yang
Journal:  Biotechnol Lett       Date:  2006-06-21       Impact factor: 2.461

3.  Metagenomic analysis of kimchi, a traditional Korean fermented food.

Authors:  Ji Young Jung; Se Hee Lee; Jeong Myeong Kim; Moon Su Park; Jin-Woo Bae; Yoonsoo Hahn; Eugene L Madsen; Che Ok Jeon
Journal:  Appl Environ Microbiol       Date:  2011-02-11       Impact factor: 4.792

4.  In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration.

Authors:  C Wakabayashi; H Hasegawa; J Murata; I Saiki
Journal:  Oncol Res       Date:  1997       Impact factor: 5.574

5.  Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng.

Authors:  Y S Keum; K K Park; J M Lee; K S Chun; J H Park; S K Lee; H Kwon; Y J Surh
Journal:  Cancer Lett       Date:  2000-03-13       Impact factor: 8.679

6.  Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.

Authors:  T Akao; H Kida; M Kanaoka; M Hattori; K Kobashi
Journal:  J Pharm Pharmacol       Date:  1998-10       Impact factor: 3.765

7.  Degradation of ginsenosides in humans after oral administration.

Authors:  Mona Abdel Tawab; Ute Bahr; Michael Karas; Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

8.  Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.

Authors:  M Mochizuki; Y C Yoo; K Matsuzawa; K Sato; I Saiki; S Tono-oka; K Samukawa; I Azuma
Journal:  Biol Pharm Bull       Date:  1995-09       Impact factor: 2.233

9.  Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata.

Authors:  Aling Dong; Min Ye; Hongzhu Guo; Junhua Zheng; Dean Guo
Journal:  Biotechnol Lett       Date:  2003-02       Impact factor: 2.461

10.  Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.

Authors:  J Y Wu; B H Gardner; C I Murphy; J R Seals; C R Kensil; J Recchia; G A Beltz; G W Newman; M J Newman
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

View more
  16 in total

1.  Changes in the ginsenoside content during the fermentation process using microbial strains.

Authors:  So Jin Lee; Yunjeong Kim; Min-Gul Kim
Journal:  J Ginseng Res       Date:  2015-05-21       Impact factor: 6.060

2.  Compound K Production from Red Ginseng Extract by β-Glycosidase from Sulfolobus solfataricus Supplemented with α-L-Arabinofuranosidase from Caldicellulosiruptor saccharolyticus.

Authors:  Kyung-Chul Shin; Hye-Yeon Choi; Min-Ju Seo; Deok-Kun Oh
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

3.  The Bioconversion of Red Ginseng Ethanol Extract into Compound K by Saccharomyces cerevisiae HJ-014.

Authors:  Hak Joo Choi; Eun A Kim; Dong Hee Kim; Kwang-Soo Shin
Journal:  Mycobiology       Date:  2014-09-30       Impact factor: 1.858

4.  Biotransformation of major ginsenosides in ginsenoside model culture by lactic acid bacteria.

Authors:  Seong-Eun Park; Chang-Su Na; Seon-A Yoo; Seung-Ho Seo; Hong-Seok Son
Journal:  J Ginseng Res       Date:  2015-12-28       Impact factor: 6.060

5.  General and Genetic Toxicology of Enzyme-Treated Ginseng Extract: Toxicology of Ginseng Rh2.

Authors:  Mi-Kyung Jeong; Chong-Kwan Cho; Hwa-Seung Yoo
Journal:  J Pharmacopuncture       Date:  2016-09

Review 6.  Study on Transformation of Ginsenosides in Different Methods.

Authors:  Meng-Meng Zheng; Fang-Xue Xu; Yu-Juan Li; Xiao-Zhi Xi; Xiao-Wei Cui; Chun-Chao Han; Xue-Lan Zhang
Journal:  Biomed Res Int       Date:  2017-12-14       Impact factor: 3.411

7.  Improved conversion of ginsenoside Rb1 to compound K by semi-rational design of Sulfolobus solfataricus β-glycosidase.

Authors:  Kyung-Chul Shin; Hye-Yeon Choi; Min-Ju Seo; Deok-Kun Oh
Journal:  AMB Express       Date:  2017-10-04       Impact factor: 3.298

8.  Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis.

Authors:  Ling Li; Soo Jin Lee; Qiu Ping Yuan; Wan Taek Im; Sun Chang Kim; Nam Soo Han
Journal:  J Ginseng Res       Date:  2017-04-21       Impact factor: 6.060

Review 9.  An Insight into Ginsenoside Metabolite Compound K as a Potential Tool for Skin Disorder.

Authors:  En Hyung Kim; Wonnam Kim
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

10.  Biosynthesis of rare 20(R)-protopanaxadiol/protopanaxatriol type ginsenosides through Escherichia coli engineered with uridine diphosphate glycosyltransferase genes.

Authors:  Lu Yu; Yuan Chen; Jie Shi; Rufeng Wang; Yingbo Yang; Li Yang; Shujuan Zhao; Zhengtao Wang
Journal:  J Ginseng Res       Date:  2017-10-16       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.